Bone Biologics Corp Liquidation Value Calculator
Bone Biologics Corp
Current Price: N/A
Loading calculator data...
Advanced: All 93 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash total | $5.33M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations |
$5.33M | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$418,587 | USD | ||
| liabilities_total | ||||
| Liabilities total | $418,587 | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
1.8M | shares | ||
Unmapped Tags (86)
| Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent | $417,884 | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $93.51M | USD | ||
| Assets Assets | $5.80M | USD | ||
| Assets Current AssetsCurrent | $5.80M | USD | ||
| Cash FDIC Insured Amount CashFDICInsuredAmount | $250,000 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $100.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $1.80M | shares | ||
| Common Stock Value CommonStockValue | $1,795 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $24.81M | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $14.14M | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch | $938,000 | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $24.81M | USD | ||
| Interest Receivable InterestReceivable | $9,895 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $5.80M | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $20.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-88.13M | USD | ||
| Stockholders Equity StockholdersEquity | $5.38M | USD | ||
| Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount | $3.13M | USD | ||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | $256,358 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $2.01M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | $7.92M | USD | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | $91,025 | USD | ||
| Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet | $9,895 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $4.70M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-2.69M | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $4.35M | USD | ||
| Share Based Compensation ShareBasedCompensation | $256,358 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | $1 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised | $456,250 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted | $3.03M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | $2.88M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | $66,811 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | $69 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | $118 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | $37,364 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | $41,932 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $55,461 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $87,777 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $54 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | $579 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | $399 | shares | ||
| Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | $200,000 | USD | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | $5 | USD/shares | ||
| Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | $87,777 | shares | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $2.97M | shares | ||
| Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | $1.81M | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-3 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-3 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | $0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $2.17M | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $1.54M | USD | ||
| Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes | $-885,062 | USD | ||
| Interest Income Other InterestIncomeOther | $121,984 | USD | ||
| Net Income Loss NetIncomeLoss | $-3.11M | USD | ||
| Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic | $-3.11M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $125,951 | USD | ||
| Operating Expenses OperatingExpenses | $3.23M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-3.23M | USD | ||
| Other Expenses OtherExpenses | $983,054 | USD | ||
| Other Research And Development Expense OtherResearchAndDevelopmentExpense | $251,999 | USD | ||
| Prepaid Expense Current PrepaidExpenseCurrent | $10,000 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $1.06M | USD | ||
| Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | $5 | USD/shares | ||
| Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | $75,000 | shares | ||
| Entity Listing Par Value Per Share EntityListingParValuePerShare | $0 | USD/shares | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $-3,967 | USD | ||
| Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease | $3,967 | USD | ||
| Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | $703 | USD | ||
| Insurance Tax InsuranceTax | $285,339 | USD | ||
| Operating Loss Carryforwards OperatingLossCarryforwards | $46.14M | USD | ||
| Other Income OtherIncome | $125,951 | USD | ||
| Profit Loss ProfitLoss | $-3.10M | USD | ||
| Share Price SharePrice | $1 | USD/shares | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $4.35M | USD | ||
| Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther | $347,549 | USD | ||
| IncreaseDecreaseInPrepaidInsurance IncreaseDecreaseInPrepaidInsurance | $-35,233 | USD | ||
| SalariesAndWages SalariesAndWages | $650,000 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.